RxDoctor Payments Data

Sonia Rivera-Martinez, DO

Family Medicine · Central Islip, NYNPI 1902869555

Payments from drug & device makers

$690in general payments, 2019–2025

Across 36 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$284
  • Abbott$147
  • AstraZeneca$68
  • Merck$57
  • Pfizer$41
  • Lilly USA, LLC$32
  • plus $61 from 3 others

What the payments were for

  • Food & beverage$690100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk15$284
Abbott7$147
AstraZeneca5$68
Merck3$57
Pfizer2$41
Lilly USA, LLC1$32
Shield Therapeutics Inc1$23
Avvisto Therapeutics, LLC1$22
Alk-abello, Inc1$16

How this compares

$690 in reported general payments places this provider in the 60th percentile of 4,321 family medicine providers in New York.

See all family medicine providers in New York

Medicare billing

Part B allowed, 2024
$7,977
Medicare patients
31
Services billed
107

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin30$48,513
FarxigaDapagliflozin Propanediol30$45,953
JanuviaSitagliptin Phosphate17$24,899
TradjentaLinagliptin16$24,799
TrulicityDulaglutide11$23,663
OzempicSemaglutide12$17,953
Tresiba Flextouch U-100Insulin Degludec11$17,701
Saxagliptin Hcl11$4,002
SymbicortBudesonide/Formoterol Fumarate11$3,991
Tramadol Hcl12$940
SynthroidLevothyroxine Sodium12$791
Rosuvastatin Calcium61$688
Metoprolol Succinate57$652
Atorvastatin Calcium86$588
Duloxetine Hcl11$504

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$68$49,94441 claims
MerckJanuvia$57$24,89917 claims
Lilly USA, LLCTrulicity$32$23,66311 claims
Novo NordiskOzempic$284$17,95312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,321 family medicine providers in New York.

Other family medicine in Central Islip

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →